[Combination of anlotinib and irinotecan in the second-line treatment of metastatic colorectal cancer: a multicenter phase 1/2 trial].

Zhang, B; Wang, X; Zhu, L J; Zhu, W Y; Li, Q; Liu, Y; Qi, L; Shu, Y Q; Huang, J

Zhang, B; Wang, X; Zhu, L J; Zhu, W Y; Li, Q; Liu, Y; Qi, L; Shu, Y Q; Huang, J.

Afiliação

Zhang B; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Wang X; Daycare Center, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Zhu LJ; Department of Medical Oncology, Jiangsu Province Hospital, Nanjing 210029, China.
Zhu WY; Department of Medical Oncology, Jiangsu Province Hospital, Nanjing 210029, China.
Li Q; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Liu Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Qi L; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Shu YQ; Department of Medical Oncology, Jiangsu Province Hospital, Nanjing 210029, China.
Huang J; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.

Zhonghua Zhong Liu Za Zhi ; 45(1): 95-100, 2023 Jan 23.

Article em Zh | MEDLINE | ID: mdl-36709126

Assuntos

Protocolos de Quimioterapia Combinada Antineoplásica; Neoplasias Colorretais; Humanos; Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos; Neoplasias Colorretais/tratamento farmacológico; Neoplasias Colorretais/patologia; Indóis/uso terapêutico; Irinotecano/uso terapêutico; Estudos Prospectivos

Palavras-chave

Anlotinib; Colorectal neoplasms; Efficacy; Irinotecan; Safety

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND / 4_TD / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Humans Idioma: Zh Revista: Zhonghua Zhong Liu Za Zhi Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google